BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18412290)

  • 1. Chronic statin therapy and the risk of colorectal cancer.
    Yang YX; Hennessy S; Propert K; Hwang WT; Sarkar M; Lewis JD
    Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):869-76. PubMed ID: 18412290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term use of statins and risk of colorectal cancer: a population-based study.
    Singh H; Mahmud SM; Turner D; Xue L; Demers AA; Bernstein CN
    Am J Gastroenterol; 2009 Dec; 104(12):3015-23. PubMed ID: 19809413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and risk of colorectal cancer.
    Coogan PF; Smith J; Rosenberg L
    J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort.
    Jacobs EJ; Rodriguez C; Brady KA; Connell CJ; Thun MJ; Calle EE
    J Natl Cancer Inst; 2006 Jan; 98(1):69-72. PubMed ID: 16391373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and cancer risk.
    Karp I; Behlouli H; Lelorier J; Pilote L
    Am J Med; 2008 Apr; 121(4):302-9. PubMed ID: 18374689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of statins for primary prevention in non-elderly colorectal cancer patients.
    Sehdev A; Shih YC; Huo D; Vekhter B; Lyttle C; Polite B
    Anticancer Res; 2014 Sep; 34(9):5043-50. PubMed ID: 25202089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of fish consumption on colorectal cancer risk. Hospital-based case-control study in Eastern Europe.
    Jedrychowski W; Maugeri U; Pac A; Sochacka-Tatara E; Galas A
    Ann Nutr Metab; 2008; 53(3-4):295-302. PubMed ID: 19169007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study.
    Mulder SA; van Soest EM; Dieleman JP; van Rossum LG; Ouwendijk RJ; van Leerdam ME; Kuipers EJ
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):437-43. PubMed ID: 19952765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin drugs and risk of advanced prostate cancer.
    Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
    J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term use of statins is associated with a decreased incidence of adenomatous colon polyps.
    Siddiqui AA; Nazario H; Mahgoub A; Pandove S; Cipher D; Spechler SJ
    Digestion; 2009; 79(1):17-22. PubMed ID: 19246916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?
    Douketis JD; Melo M; Bell CM; Mamdani MM
    Am J Med; 2007 Apr; 120(4):369.e9-369.e14. PubMed ID: 17398234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study.
    Friis S; Poulsen AH; Sørensen HT; Tjønneland A; Overvad K; Vogel U; McLaughlin JK; Blot WJ; Olsen JH
    Cancer Causes Control; 2009 Jul; 20(5):731-40. PubMed ID: 19122977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for statin-associated rhabdomyolysis.
    Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of colorectal cancer in women with a prior diagnosis of gynecologic malignancy.
    Srinivasan R; Yang YX; Rubin SC; Morgan MA; Lewis JD
    J Clin Gastroenterol; 2007 Mar; 41(3):291-6. PubMed ID: 17426469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study.
    Lakoff J; Paszat LF; Saskin R; Rabeneck L
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1117-21; quiz 1064. PubMed ID: 18691942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and newly diagnosed diabetes.
    Jick SS; Bradbury BD
    Br J Clin Pharmacol; 2004 Sep; 58(3):303-9. PubMed ID: 15327590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of cancer in users of statins.
    Graaf MR; Beiderbeck AB; Egberts AC; Richel DJ; Guchelaar HJ
    J Clin Oncol; 2004 Jun; 22(12):2388-94. PubMed ID: 15197200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.
    Lipkin SM; Chao EC; Moreno V; Rozek LS; Rennert H; Pinchev M; Dizon D; Rennert G; Kopelovich L; Gruber SB
    Cancer Prev Res (Phila); 2010 May; 3(5):597-603. PubMed ID: 20403997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
    Koro CE; Sowell MO; Stender M; Qizilbash N
    Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study.
    Limburg PJ; Vierkant RA; Fredericksen ZS; Leibson CL; Rizza RA; Gupta AK; Ahlquist DA; Melton LJ; Sellers TA; Cerhan JR
    Am J Gastroenterol; 2006 Aug; 101(8):1872-9. PubMed ID: 16790032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.